Close
Form DEFA14A Ampio Pharmaceuticals, Oct 4, 2022 09:08AM http://archive.fast-edgar.com/20221004/ASZQBG2CZC22PZ3E222B2ZZ2PLW9ZM2IZ242 Filed on: October 4, 2022
Form DEFA14A SLR Investment Corp. Oct 4, 2022 09:07AM

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

SCHEDULE 14A

(RULE 14a-101)

Information Required in Proxy Statement

Schedule 14A Information

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

 

Filed by the Registrant  ☒                            Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

  Preliminary Proxy Statement

... (continue reading...)


Form 424B2 CITIGROUP INC Oct 4, 2022 09:06AM

The information in this preliminary pricing supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, underlying supplement, prospectus supplement and prospectus are not an offer to sell these securities, nor are they soliciting an offer to buy these securities, in... (continue reading...)


Form 6-K XORTX Therapeutics Inc. For: Oct 04 Oct 4, 2022 09:06AM  

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2022

Commission File Number: 001-40858

XORTX Therapeutics Inc.

Suite 2400 - 745 Thurlow Street, Vancouver, British Columbia, Canada, V6E 0C5

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.Form 20-F... (continue reading...)


Form 8-K Weave Communications, For: Sep 30 Oct 4, 2022 09:03AM 0001609151FALSE00016091512022-09-302022-09-30UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934Date of Report (Date of earliest event reported): September 30, 2022WEAVE COMMUNICATIONS, INC.(Exact name of registrant as specified in its charter)Delaware001-4099826-3302902(State or other jurisdiction of incorporation or organization)(CommissionFile Number)(I.R.S.... (continue reading...)

More SEC Filings

View Older Stories

Oct 4, 2022 09:03AM Form 8-K Territorial Bancorp Inc. For: Sep 28
Oct 4, 2022 09:01AM Form 4 PERMA FIX ENVIRONMENTAL For: Oct 03 Filed by: ZWECKER MARK A
Oct 4, 2022 09:01AM Form 8-K Silvergate Capital Corp For: Oct 04
Oct 4, 2022 09:01AM Form 4 PERMA FIX ENVIRONMENTAL For: Oct 03 Filed by: Bostick Thomas
Oct 4, 2022 09:01AM Form 4 Ocuphire Pharma, Inc. For: Oct 03 Filed by: Rodgers Richard J
Oct 4, 2022 09:01AM Form 8-K Clarus Corp For: Sep 30
Oct 4, 2022 09:01AM Form 8-K Sharps Technology Inc. For: Sep 29
Oct 4, 2022 09:01AM Form 8-K YETI Holdings, Inc. For: Sep 29
Oct 4, 2022 09:01AM Form 4 PERMA FIX ENVIRONMENTAL For: Oct 03 Filed by: Grumski Joseph Timothy
Oct 4, 2022 09:01AM Form 4 PERMA FIX ENVIRONMENTAL For: Oct 03 Filed by: Duggan Kerry C
Oct 4, 2022 09:00AM Form SC 13D/A GENCO SHIPPING & TRADING Filed by: CCP II Cayman GP Ltd.
Oct 4, 2022 09:00AM Form 4 PERMA FIX ENVIRONMENTAL For: Oct 03 Filed by: Wamp Zach Paul
Oct 4, 2022 09:00AM Form DEFA14A Ampio Pharmaceuticals,
Oct 4, 2022 08:59AM Form D WorkFusion, Inc.
Oct 4, 2022 08:59AM Form 6-K YAMANA GOLD INC. For: Oct 04
Oct 4, 2022 08:59AM Form 8-K SUN COMMUNITIES INC For: Oct 04
Oct 4, 2022 08:57AM Form 6-K Evaxion Biotech A/S For: Oct 04
Oct 4, 2022 08:53AM Form 6-K Maxeon Solar Technologie For: Oct 04
Oct 4, 2022 08:53AM Form 424B5 Evaxion Biotech A/S
Oct 4, 2022 08:52AM Form 8-K Ampio Pharmaceuticals, For: Oct 03
Oct 4, 2022 08:52AM Form 8-K NovelStem International For: Sep 29
Oct 4, 2022 08:51AM Form 497J Franklin High Income
Oct 4, 2022 08:51AM Form 8-K/A Integrated Cannabis Solu For: Sep 01
Oct 4, 2022 08:49AM Form PRE 14C COLUMBIA FUNDS SERIES For: Oct 04
Oct 4, 2022 08:47AM Form D Third Wave Recovery Syst
Oct 4, 2022 08:46AM Form 8-K AIR INDUSTRIES GROUP For: Oct 04
Oct 4, 2022 08:46AM Form 8-K OMNIQ Corp. For: Oct 04
Oct 4, 2022 08:40AM Form 425 Zymeworks Inc. Filed by: Zymeworks Inc.
Oct 4, 2022 08:38AM Form 8-K WELLTOWER INC. For: Oct 04
Oct 4, 2022 08:38AM Form 4 Pineapple Energy Inc. For: Sep 28 Filed by: NORTHERN PACIFIC GROWTH INVESTMENT ADVISORS, LLC
Oct 4, 2022 08:37AM Form 4 CLEVELAND-CLIFFS INC. For: Oct 03 Filed by: Taylor Douglas C
Oct 4, 2022 08:37AM Form 4 CLEVELAND-CLIFFS INC. For: Oct 03 Filed by: Stoliar Gabriel
Oct 4, 2022 08:36AM Form 4 CLEVELAND-CLIFFS INC. For: Oct 03 Filed by: Miller Janet L
Oct 4, 2022 08:36AM Form 4 CLEVELAND-CLIFFS INC. For: Oct 03 Filed by: Fisher Robert P Jr
Oct 4, 2022 08:36AM Form 8-K Zymeworks Inc. For: Oct 04
Oct 4, 2022 08:36AM Form 4 EZCORP INC For: Sep 30 Filed by: Powell John Blair Jr.
Oct 4, 2022 08:34AM Form 6-K Ucommune International For: Oct 04
Oct 4, 2022 08:32AM Form S-1/A Castellum, Inc.
Oct 4, 2022 08:31AM Form 8-K CENTERPOINT ENERGY RESOU For: Oct 04 Filed by: CENTERPOINT ENERGY INC
Oct 4, 2022 08:31AM Form 8-K Microbot Medical Inc. For: Oct 04
Oct 4, 2022 08:31AM Form 8-K IIOT-OXYS, Inc. For: Oct 04
Oct 4, 2022 08:31AM Form 8-K 180 Life Sciences Corp. For: Sep 30
Oct 4, 2022 08:31AM Form 4 MILLERKNOLL, INC. For: Oct 03 Filed by: Owen Andrea
Oct 4, 2022 08:31AM Form 8-K KULR Technology Group, For: Oct 04
Oct 4, 2022 08:30AM Form 8-K VIVEVE MEDICAL, INC. For: Oct 04
Oct 4, 2022 08:28AM Form 424B5 Aterian, Inc.
Oct 4, 2022 08:26AM Form 8-K Duke Energy CORP For: Oct 04
Oct 4, 2022 08:25AM Form 425 Genesis Growth Tech Acqu Filed by: Genesis Growth Tech Acquisition Corp.
Oct 4, 2022 08:24AM Form 4 HARSCO CORP For: Sep 30 Filed by: Minan Peter Francis
Oct 4, 2022 08:24AM Form 8-K Vir Biotechnology, Inc. For: Sep 28
View Older Stories